Cannon Global Investment Management’s Avidity Biosciences RNAM Stock Holding History

Cannon Global Investment Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,500	Closed	-$1.05M	–	98
2025 Q4	$1.05M	Buy	+14,500	New	+$937K	2.63%	11

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Cannon Global Investment Management's RNAM Position: Q1 2026 in Review

Cannon Global Investment Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 14,500 shares — an estimated $1.05M sold.

Cannon Global Investment Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $1.05M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Cannon Global Investment Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Cannon Global Investment Management sold 14,500 Avidity Biosciences shares in Q1 2026, an estimated $1.05M.
Cannon Global Investment Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Cannon Global Investment Management's Avidity Biosciences position peaked at $1.05M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Cannon Global Investment Management's 13F filing for Q1 2026, filed 21 Apr 2026.